Pozo-Rosich P - Search Results

1

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P, Poveda JL, Crespo C, Martínez M, Rodríguez JM, Irimia P. Pozo-Rosich P, et al. J Headache Pain. 2024 Mar 15;25(1):40. doi: 10.1186/s10194-024-01747-w. J Headache Pain. 2024. PMID: 38491460 Free PMC article.

2

[Chronic migraine: its epidemiology and impact].

Pozo-Rosich P. Pozo-Rosich P. Rev Neurol. 2012 Apr 10;54 Suppl 2:S3-11. Rev Neurol. 2012. PMID: 22532240 Free article. Review. Spanish.

3

[Importance of diagnosis and treatment in chronic migraine].

Pozo-Rosich P. Pozo-Rosich P. Rev Neurol. 2014 Mar 10;58 Suppl 2:S1. Rev Neurol. 2014. PMID: 24687879 Free article. Spanish.

4

[What benefits does the preventive treatment of migraine have?].

Pozo-Rosich P. Pozo-Rosich P. Rev Neurol. 2014 Mar 10;58 Suppl 2:S21-6. Rev Neurol. 2014. PMID: 24687881 Free article. Spanish.

5

When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month.

Torres-Ferrús M, Quintana M, Fernandez-Morales J, Alvarez-Sabin J, Pozo-Rosich P. Torres-Ferrús M, et al. Cephalalgia. 2017 Feb;37(2):104-113. doi: 10.1177/0333102416636055. Epub 2016 Jul 11. Cephalalgia. 2017. PMID: 26961321

6

Comorbidity between idiopathic overactive bladder and chronic migraine.

Ramos ML, García-Cabo C, Leira R, Domínguez C, Pozo-Rosich P, Vila C, Laínez MJ, Pascual J. Ramos ML, et al. Cephalalgia. 2018 Mar;38(3):581-584. doi: 10.1177/0333102417690127. Epub 2017 Jan 23. Cephalalgia. 2018. PMID: 28114808

7

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis.

Matharu M, Halker R, Pozo-Rosich P, DeGryse R, Manack Adams A, Aurora SK. Matharu M, et al. J Headache Pain. 2017 Dec;18(1):78. doi: 10.1186/s10194-017-0784-4. Epub 2017 Aug 1. J Headache Pain. 2017. PMID: 28766236 Free PMC article. Clinical Trial.

8

Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice.

Gago-Veiga AB, Santos-Lasaosa S, Cuadrado ML, Guerrero ÁL, Irimia P, Láinez JM, Leira R, Pascual J, Sanchez Del Río M, Viguera J, Pozo-Rosich P. Gago-Veiga AB, et al. Neurologia (Engl Ed). 2019 Jul-Aug;34(6):408-417. doi: 10.1016/j.nrl.2017.09.008. Epub 2017 Nov 21. Neurologia (Engl Ed). 2019. PMID: 29169810 Free article. Review. English, Spanish.

9

Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine.

Santos-Lasaosa S, Cuadrado ML, Gago-Veiga AB, Guerrero-Peral AL, Irimia P, Láinez JM, Leira R, Pascual J, Porta-Etessam J, Sánchez Del Río M, Viguera Romero J, Pozo-Rosich P. Santos-Lasaosa S, et al. Neurologia (Engl Ed). 2020 Oct;35(8):568-578. doi: 10.1016/j.nrl.2017.09.003. Epub 2017 Nov 21. Neurologia (Engl Ed). 2020. PMID: 29169811 Free article. Review. English, Spanish.

10

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.

Tassorelli C, Diener HC, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ; International Headache Society Clinical Trials Standing Committee. Tassorelli C, et al. Cephalalgia. 2018 Apr;38(5):815-832. doi: 10.1177/0333102418758283. Epub 2018 Mar 4. Cephalalgia. 2018. PMID: 29504482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page